These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38804606)

  • 1. Methadone's Resurgence in Bridging the Treatment Gap in the Overdose Crisis: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education, Research, Substance Use, and Addiction).
    Suen LW; Incze M; Simon C; Englander H; Bratberg J; Groves Scott G; Winograd R
    Subst Use Addctn J; 2024 Jul; 45(3):337-345. PubMed ID: 38804606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19.
    Brothers S; Viera A; Heimer R
    J Subst Abuse Treat; 2021 Dec; 131():108449. PubMed ID: 34098303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "The idea is to help people achieve greater success and liberty": A qualitative study of expanded methadone take-home access in opioid use disorder treatment.
    Suen LW; Castellanos S; Joshi N; Satterwhite S; Knight KR
    Subst Abus; 2022; 43(1):1143-1150. PubMed ID: 35499469
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparing methadone policy and practice in France and the US: Implications for US policy reform.
    Englander H; Chappuy M; Krawczyck N; Bratberg J; Potee R; Jauffret-Roustide M; Rolland B
    Int J Drug Policy; 2024 Jul; 129():104487. PubMed ID: 38878588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss, liberation, and agency: Patient experiences of methadone treatment at opioid treatment programs during the COVID-19 pandemic.
    López-Castro T; Jakubowski A; Masyukova M; Peterson M; Pierz A; Kodali S; Arnsten JH; Starrels JL; Nahvi S
    J Subst Use Addict Treat; 2024 Feb; 157():209235. PubMed ID: 38061636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Get in and get out, get on with life": Patient and provider perspectives on methadone van implementation for opioid use disorder treatment.
    Suen LW; Steiger S; Shapiro B; Castellanos S; Joshi N; Lambdin BH; Knight KR
    Int J Drug Policy; 2023 Nov; 121():104214. PubMed ID: 37778132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic changes in methadone utilisation for opioid use disorder treatment: a retrospective observational study during the COVID-19 pandemic.
    Kennalley AL; Fanelli JL; Furst JA; Mynarski NJ; Jarvis MA; Nichols SD; McCall KL; Piper BJ
    BMJ Open; 2023 Nov; 13(11):e074845. PubMed ID: 37973543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slow release oral morphine versus methadone for opioid use disorder in the fentanyl era (pRESTO): Protocol for a non-inferiority randomized clinical trial.
    Socias ME; Wood E; Dong H; Brar R; Bach P; Murphy SM; Fairbairn N
    Contemp Clin Trials; 2020 Apr; 91():105993. PubMed ID: 32194251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving methadone access for rural communities in the USA: lessons learned from COVID-19 adaptations and international models of care.
    Lister JJ; Lister HH
    Rural Remote Health; 2021 Nov; 21(4):6770. PubMed ID: 34757760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoption of methadone take home policy by U.S. state opioid treatment authorities during COVID-19.
    Roy V; Buonora M; Simon C; Dooling B; Joudrey P
    Int J Drug Policy; 2024 Feb; 124():104302. PubMed ID: 38183861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adapting methadone inductions to the fentanyl era.
    Buresh M; Nahvi S; Steiger S; Weinstein ZM
    J Subst Abuse Treat; 2022 Oct; 141():108832. PubMed ID: 35870437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM
    JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19-related policy changes for methadone take-home dosing: A multistate survey of opioid treatment program leadership.
    Levander XA; Pytell JD; Stoller KB; Korthuis PT; Chander G
    Subst Abus; 2022; 43(1):633-639. PubMed ID: 34666636
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of COVID-19-related methadone regulatory flexibilities: views of state opioid treatment authorities and program staff.
    Mitchell SG; Jester J; Gryczynski J; Whitter M; Fuller D; Halsted C; Schwartz RP
    Addict Sci Clin Pract; 2023 Oct; 18(1):61. PubMed ID: 37848970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis.
    Levander XA; Hoffman KA; McIlveen JW; McCarty D; Terashima JP; Korthuis PT
    Addict Sci Clin Pract; 2021 Dec; 16(1):72. PubMed ID: 34895346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing Canadian and United States opioid agonist therapy policies.
    Priest KC; Gorfinkel L; Klimas J; Jones AA; Fairbairn N; McCarty D
    Int J Drug Policy; 2019 Dec; 74():257-265. PubMed ID: 30765118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "No home to take methadone to": Experiences with addiction services during the COVID-19 pandemic among survivors of opioid overdose in Boston.
    Harris MTH; Lambert AM; Maschke AD; Bagley SM; Walley AY; Gunn CM
    J Subst Abuse Treat; 2022 Apr; 135():108655. PubMed ID: 34772604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Medicaid Expansion With Opioid Overdose Mortality in the United States.
    Kravitz-Wirtz N; Davis CS; Ponicki WR; Rivera-Aguirre A; Marshall BDL; Martins SS; Cerdá M
    JAMA Netw Open; 2020 Jan; 3(1):e1919066. PubMed ID: 31922561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A health crisis within a health crisis: Opioid access in the COVID-19 pandemic.
    Narayan A; Balkrishnan R
    Subst Abus; 2021; 42(2):148-152. PubMed ID: 33849399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unintended consequences of methadone regulation for opioid use disorder treatment among hospitalized patients.
    Calcaterra SL; Dafoe A; Tietbohl C; Thurman L; Bredenberg E
    J Hosp Med; 2024 Jun; 19(6):460-467. PubMed ID: 38507276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.